Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| CHOL | CHOLERA (VAXCHORA) | PAXVAX | 1 | Unknown | PO / MO |
The patient took antibiotic in the morning before administration of Vaxchora vaccine; Case reference number US-BN-2024-002179 is a spontaneous case initially received from nurse via Communications (reference number USBAV24-1613) on 10-Jul-2024 and concerns a male patient of unspecified age. The patient's current condition included Infected cyst. The patient's concomitant medications included antibiotic (brand name unknown). On an unspecified date, as reported the patient completed an antibiotic in the morning, and the patient forgot to tell nurse before administration of a dose of Vaxchora (batch number: unknown), at an unknown dose, orally, for unknown indication (explicitly coded 'labelled drug-drug interaction medication error'). At the time of the initial report, it was unknown if the patient experienced an adverse event due to Vaxchora. No further information was provided.; Reporter's Comments: A male patient of unspecified age completed an antibiotic in the morning, and the patient forgot to tell the nurse before administration of a dose of Vaxchora for unknown indication, which is considered as labelled drug-drug interaction medication error. It was unknown if the patient experienced an adverse event due to Vaxchora. Labelled drug-drug interaction medication error is considered as listed per company convention. The patient's current condition included infected cyst, and concomitant medications included antibiotic. Labelled drug-drug interaction medication error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unspecified age completed an antibiotic in the morning, and the patient forgot to tell the nurse before administration of a dose of Vaxchora for unknown indication, which is considered as labelled drug-drug interaction medication error. It was unknown if the patient experienced an adverse event due to Vaxchora. Labelled drug-drug interaction medication error is considered as listed per company convention. The patient's current condition included infected cyst, and concomitant medications included antibiotic. Labelled drug-drug interaction medication error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Infected cyst
ANTIBIOTICS